New blood filter could save lives in septic shock

NCT ID NCT06692036

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new blood-filtering method called adaptive blood purification (ABP) for people with septic shock. The treatment aims to remove inflammatory substances from the blood. 276 adults in intensive care will be randomly assigned to receive either standard care or standard care plus two 6-hour ABP sessions. The main goal is to see if ABP reduces deaths within 90 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Adaptive blood purification (a blood-filtering procedure that removes inflammatory substances, with or without dialysis)
What this could lead to
If it works, this could offer a new way to reduce deaths from septic shock by filtering harmful substances from the blood.
What could go wrong
This is an early-stage study with no prior proof of benefit. The procedure is complex and may not improve survival. Risks include complications from blood filtering.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Chao Yang Hospital

    Beijing, Beijing Municipality, 100020, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.